Lisata Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.40

+0.01 (+0.30%)

As of Jun 30, 10:42 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +837.6% upside

Low Target $19.01

Average Target $31.88

High Target $45.37

Current Price $3.40

Current
$3.40

Target
$31.88

$19.01 $31.88 avg $45.37

Scenario Analysis

Bear Case

$19.01

459.1%

Low target

Base Case

$31.88

+837.6%

Avg target

Bull Case

$45.37

+1,234.4%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$5.07

-32.9% from high

52-Week Low

$1.81

+87.8% from low

Target vs 52W High

$31.88

+528.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%